During the exhibition, Shinsung TK held meetings with 45 companies at its booth, identifying the needs of investors and understanding the market of each country. Not only was the technological excellence of its IoT-based iRINGER IV Infusion Monitoring System universally recognized, but Shinsung TK affirmed its potential as a partner as well, having collaborated with various companies around the world and playing a major role in technology development.
iRINGER, a smart Infusion Monitoring System, automatically calculates the amount and speed (cc/hr) of the infusion, and uses wireless technology to inform nurses and medical personnel outside the hospital ward via smartphone or PC web. It also provides an alarm (sound and vibration) through a smart call (automatic transmission) when an anomaly occurs.
Shinsung TK has been participating in the health care exhibition annually since 2016, promoting its product technology continuously to establish its position in the overseas medical market. Recently, the use of iRINGER has increased as non-face-to-face treatment has become an issue with the spread of COVID-19.
Eunseop Lim, the CEO of Shinsung TK, said "Based on our IoT remote infusion monitoring technology, which is the result of continuous technology investment and innovation, the company plans to expand its smart healthcare platform technology in the future to measures not only the infusion, but also the patient's body temperature and pulse, temperature and humidity, and urine volume."
Shinsung TK signed an MOU agreement with the Malaysian company LKL in 2019. It will participate in the Medicine 4.0 conference with LKL at Malaysia's Matrade Convention Center for two days from August 8th - 9th 2020 to showcase its technology.
Media contact
SHINSUNG TK Co., Ltd.
Contact: Eun Suab Lim
Email: sstop77@shinsungtk.com
Phone: +82-62-972-0629
Website: http://shinsungtk.com/en/
Copyright 2020 JCN Newswire. All rights reserved. www.jcnnewswire.com Via JCN Newswire https://ift.tt/2pbRN02